Evidence map›Paper›PMID 29432837›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2018

Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling.

Subramanyam Dasari, Angela Lincy Prem Antony Samy, Andre Kajdacsy-Balla, Maarten C Bosland, Gnanasekar Munirathinam

Open access · greenAbstract read
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Subramanyam DasariDepartment of Biomedical Sciences, University of Illinois-College of Medicine, Rockford, IL, USA.
Angela Lincy Prem Antony SamyDepartment of Biomedical Sciences, University of Illinois-College of Medicine, Rockford, IL, USA.
Andre Kajdacsy-BallaDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Maarten C BoslandDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Gnanasekar MunirathinamDepartment of Biomedical Sciences, University of Illinois-College of Medicine, Rockford, IL, USA. Electronic address: mgnanas@uic.edu.
University of Illinois Urbana-Champaign · USUniversity of Illinois Chicago · US

Funding

Managing prostate cancer metastasis using vitamin k2R21CA184646 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MUNIRATHINAM, GNANASEKAR · 2015 to 2016
$382k
NCI NIH HHS R21 CA184646
6 · The paper itself

Abstract

The aim of this study was to evaluate the therapeutic effects of vitamin K2 (VK2) on castration-resistant prostate cancer (CRPC) and its anti-cancer mechanisms in a pre-clinical study using a VCaP cell line (ATCC

Indexed as

OrchiectomyAntineoplastic AgentsApoptosisBlotting, WesternCell CycleCell Line, TumorCell ProliferationCellular SenescenceDairy ProductsHumansMaleProstate-Specific AntigenProstatic Neoplasms, Castration-ResistantReactive Oxygen SpeciesSignal TransductionVitamin K 2Antineoplastic AgentsProstate-Specific AntigenReactive Oxygen SpeciesVitamin K 2ApoptosisProstate cancerReactive oxygen species and DNA damageVitamin K2

Identifiers

PMID29432837
PMCPMC5935569
OpenAlexW2792240039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.